News Jun 23, 2023
Serge Kechichian Joins Forces for a Charitable Swing at the DCAT Scholarship Golf Outing
Our very own Serge Kechichian is all set to tee it up for a cause with colleagues, suppliers, and customers in support of the DCAT (Drug, Chemical & Associated Technologies Association) Scholarship golf outing. Under DCAT’s Science and Scholarship Committee’s scholarship program, the event will be held on June 26 at TPC Jasna Polana in Princeton, NJ. It aims to raise funds to provide education to high school students from around the globe and help them fulfill their passion.
News Jun 23, 2023
Yuriy Abramov, Ph.D., to Present Groundbreaking Insights on Computational Studies of Pharmaceutical Crystals at the 6th David Grand Symposium
Join J-STAR Research, Inc. Executive Director of computational chemistry and datas science, Yuriy Abramov, Ph.D., as he takes the stage as an invited speaker at the 6th David Grand Symposium on June 15. He will share his insights on computational Studies on the crystallization development and characterization of pharmaceutical crystals, and engage in meaningful discussions with fellow experts in the field. Looking forward to connecting, learning, and making new connections at this prestigious event.
News Jun 23, 2023
Dr. Angelo Maria Manzo of Porton Pharma Solutions Joins BOS Basel 2023, Spearheading Collaborations and Growth Opportunities
Dr. Angelo Maria Manzo, our esteemed Senior Business Development Manager at Porton Pharma Solutions Ltd., joins us at BOS Basel 2023!Angelo’s deep industry knowledge and strategic vision are set to make a remarkable impact as he explores new collaborations, identifies growth opportunities, and expands our network.Drop by Stand 17 to catch up with him during the 2-day event in Basel, Switzerland!
News Jun 23, 2023
Porton Pharma Solutions Launches State-of-the-Art Small Molecule Platform in Shanghai, Elevating CDMO Services
We are thrilled to announce the establishment of our state-of-the-art Small Molecule Platform in Shanghai, revolutionizing our CDMO services. With this exciting development, Porton Pharma Solutions Ltd. now have seven R&D and production facilities in Shanghai that are equipped to provide comprehensive solutions for drug substance, drug preparation, synthetic macromolecules, and biological macromolecules.
News Jun 23, 2023
Porton Pharma Solutions Welcomes Dr. Wenfang Miao as CEO of Porton USA, L.L.C. and J-STAR Research, Inc., Ushering in a New Era of Pharmaceutical Innovation
Join us in welcoming Dr. Wenfang Miao (Renee) as the new CEO of Porton USA, L.L.C. and J-STAR Research, Inc., and Vice-President of Porton Pharma Solutions, LTD. Dr. Miao brings with her more than 25 years of experience in technical, operational, and strategic leadership within the pharmaceutical industry as she will navigate Porton’s overall business strategies, operations, and business development and growth in the United States. We are looking forward to Porton’s stronger foothold in pharmaceutical innovation with her leadership. We are rooting for you, Dr. Miao!
News Jun 23, 2023
Porton Pharma Solutions Welcomes Alexandra Pichard Nielsen, VP of Business Development, at BOS Basel 2023, Driving Innovation and Growth in the Pharmaceutical Industry
We’re honored to have Alexandra Pichard Nielsen, Vice President for Business Development at Porton Pharma Solutions Ltd., join us at BOS Basel 2023!
News Jun 23, 2023
Porton Pharma Solutions Expands Global Reach with New Site in Slovenia and Enhanced Manufacturing Capabilities
Porton Pharma Solutions Ltd. continues to expand its reach globally. Last year, we launched the construction of a new site in Menges, Slovenia. The state-of-the-art GMP manufacturing site will significantly expand Porton’s network beyond China and the US as it sets out to provide solutions to customers and partners in Europe.
News Jun 23, 2023
[Important Notice] Porton Announcement Regarding the Change of Email Domain
Porton Pharma Solutions Ltd. continues to expand its reach globally. Last year, we launched the construction of a new site in Menges, Slovenia. The state-of-the-art GMP manufacturing site will significantly expand Porton’s network beyond China and the US as it sets out to provide solutions to customers and partners in Europe.
News May 14, 2023
Porton Unveils Its Small Molecule Platform Headquarters in Shanghai
NEW YORK, NY - On March 20th through March 23rd, 2023, Midtown New York City was home to the 95th Annual DCAT Week, one of the world’s largest and highly recognized and attended business events for the pharmaceutical industry.
